Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Digestive Diseases and Sciences|November 4, 2017
Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with CirrhosisGiuseppe Cullaro, Grace Kim, Marcus R Pereira, et al.
Transplantation|January 5, 2018
Early Postoperative Neutrophil Gelatinase-Associated Lipocalin Predicts the Development of Chronic Kidney Disease After Liver TransplantationGiuseppe Cullaro, Joseph F Pisa, Robert S Brown, et al.
Clinical Transplantation|November 8, 2023
Association between neighborhood-based material deprivation and liver transplant waitlist registrants demographics and mortalityGiuseppe Cullaro, Jin Ge, Brian P Lee, et al.
Hepatology Communications|September 27, 2023
Nonselective beta-blockers may lead to stage 2 acute kidney injury and waitlist mortality in child class C cirrhosisMason Lai, Cynthia Fenton, Jin Ge, et al.
Transplantation|December 16, 2020
Sex-based Disparities in Hepatocellular Carcinoma Recurrence After Liver TransplantationGiuseppe Cullaro, Jessica Rubin, Neil Mehta, et al.
Hepatology (Baltimore, Md.)|March 7, 2025
The relationship between mean arterial pressure and terlipressin in hepatorenal syndrome-acute kidney injury reversal: A post hoc analysisGiuseppe Cullaro, Andrew S Allegretti, Kavish R Patidar, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 23, 2024
Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among patients with decompensated cirrhosisGiuseppe Cullaro, Andrew S Allegretti, Kavish R Patidar, et al.
Research Square|May 20, 2024
Applying Metabolomics and Aptamer-based Proteomics to Determine Pathophysiologic Differences in Decompensated Cirrhosis Patients Hospitalized with Acute Kidney InjuryGiuseppe Cullaro, Andrew S Allegretti, Kavish R Patidar, et al.
Digestive Diseases and Sciences|August 1, 2025
Applying Metabolomics and Aptamer-Based Proteomics to Determine Pathophysiologic Differences in Decompensated Cirrhosis Patients Hospitalized with Acute Kidney InjuryGiuseppe Cullaro, Andrew S Allegretti, Kavish R Patidar, et al.
Hepatology (Baltimore, Md.)|April 8, 2026
OCE-205, a selective V1a receptor mixed agonist-antagonist, for the treatment of hepatorenal syndrome-acute kidney injury: A phase 2 randomized trialAndrew S Allegretti, Giuseppe Cullaro, Paul Kwo, et al.
Pageof 7